Intestinal Microbiome in Dogs with Chronic Hepatobiliary Disease: Can We Talk about the Gut-Liver Axis?

被引:3
|
作者
Habermaass, Verena [1 ]
Olivero, Daniela [2 ]
Gori, Eleonora [1 ]
Mariti, Chiara [1 ]
Longhi, Erika [3 ]
Marchetti, Veronica [1 ]
机构
[1] Univ Pisa, Dept Vet Sci, Via Livornese Lato Monte, I-56122 Pisa, Italy
[2] Anal Lab BSA Scilvet, Via A Aosta 7, I-20129 Milan, Italy
[3] Anal Lab Labospace, Via Apelle 41, I-20128 Milan, Italy
来源
ANIMALS | 2023年 / 13卷 / 20期
关键词
canine microbiota; gut microbiota; dysbiosis; hepatopathy; canine hepatic disease; liver-gut axis; BILE-ACIDS; FECAL MICROBIOTA; CATS; METABOLISM; CANINE; DIET;
D O I
10.3390/ani13203174
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Simple Summary The interaction between gut and liver is currently considered for the management of humans with chronic hepatobiliary disease (CHD). The gut microbiota (GM) is considered to strongly mediate this crosstalk. The present study aimed to evaluate the GM in dogs diagnosed with CHD. Comparison among CHD dogs were made with respect to some clinical and biochemical variables. Sixty-five dogs were prospectively enrolled. Clinical and hematobiochemical evaluation together with GM sequencing was performed. Several GM modifications were observed, with cholestasis apparently associated with deeper GM alteration. For the management of dogs with CHD and especially cholestatic CHD, clinicians should be aware that gut-liver interaction may lead to dysbiosis.Abstract The gut-liver axis represents a current topic in human medicine. Extensive research investigates the gut microbiome (GM) modifications in relation to various kinds of chronic hepatobiliary diseases (CHD), with many mechanisms and therapeutical implications recognized. Those aspects in veterinary medicine are still quite unexplored. The aim of the present study was to evaluate GM in dogs diagnosed with CD. Comparison among CHD dogs were made considering some clinical and biochemical variables (lipemia and alanine-aminotransferase activities), presence of cholestasis or endocrine disorders, diet). Sixty-five dogs were prospectively enrolled with clinical and hematobiochemical evaluation and 16S-RNA GM sequencing assessed. Dogs that received antibiotics and/or pre/pro/symbiotics administration were excluded. Deeper GM alteration was observed between dogs with or without ultrasonographic and biochemical cholestatic CHD. Cholestasis was associated with a decrease in several bacterial taxa, including Clostridium hiranonis, Fusobacterium, Megamonas, Ruminococcus faecis, Turicibacter, and higher levels of Escherichia/Shigella and Serratia. Thus, the alteration in bile flow and composition, typical of cholestasis, may directly affect the local intestinal microbial environment. For the management of dogs with CHD and especially cholestatic CHD, clinicians should be aware that gut-liver interaction may lead to dysbiosis.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] HEPATOBILIARY PHENOTYPE OF INDIVIDUALS WITH CHRONIC INTESTINAL DISORDERS - THE GUT-LIVER AXIS IN UKBIOBANK
    Voss, Jessica
    Schneider, Carolin Victoria
    Kleinjans, Moritz
    Bruns, Tony
    Trautwein, Christian
    Strnad, Pavel
    HEPATOLOGY, 2021, 74 : 358A - 358A
  • [2] Hepatobiliary Phenotype of Individuals with Chronic Intestinal Disorders-The Gut-Liver Axis in UKBiobank
    Voss, Jessica
    Schneider, Carolin Victoria
    Kleinjans, Moritz
    Bruns, Tony
    Trautwein, Christian
    Strnad, Pavel
    JOURNAL OF HEPATOLOGY, 2021, 75 : S405 - S406
  • [3] The gut-liver axis in hepatobiliary diseases
    Masataka Ichikawa
    Haruka Okada
    Nobuhiro Nakamoto
    Nobuhito Taniki
    Po-Sung Chu
    Takanori Kanai
    Inflammation and Regeneration, 44
  • [4] The gut-liver axis in hepatobiliary diseases
    Ichikawa, Masataka
    Okada, Haruka
    Nakamoto, Nobuhiro
    Taniki, Nobuhito
    Chu, Po-Sung
    Kanai, Takanori
    INFLAMMATION AND REGENERATION, 2024, 44 (01)
  • [5] Viral Liver Disease and Intestinal Gut-Liver Axis
    Kouroumalis, Elias
    Tsomidis, Ioannis
    Voumvouraki, Argyro
    GASTROINTESTINAL DISORDERS, 2024, 6 (01): : 64 - 93
  • [6] The gut-liver axis and the intersection with the microbiome
    Tripathi, Anupriya
    Debelius, Justine
    Brenner, David A.
    Karin, Michael
    Loomba, Rohit
    Schnabl, Bernd
    Knight, Rob
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (07) : 397 - 411
  • [7] The Gut-Liver Axis in Chronic Liver Disease: A Macrophage Perspective
    De Muynck, Kevin
    Vanderborght, Bart
    Van Vlierberghe, Hans
    Devisscher, Lindsey
    CELLS, 2021, 10 (11)
  • [8] Influence of Gut-Liver Axis on Portal Hypertension in Advanced Chronic Liver Disease: The Gut Microbiome as a New Protagonist in Therapeutic Management
    Santopaolo, Francesco
    Coppola, Gaetano
    Giuli, Lucia
    Gasbarrini, Antonio
    Ponziani, Francesca Romana
    MICROBIOLOGY RESEARCH, 2022, 13 (03) : 539 - 555
  • [9] The microbiome and autoimmunity: a paradigm from the gut-liver axis
    Li, Bo
    Selmi, Carlo
    Tang, Ruqi
    Gershwin, M. E.
    Ma, Xiong
    CELLULAR & MOLECULAR IMMUNOLOGY, 2018, 15 (06) : 595 - 609
  • [10] Alcoholic liver disease and the gut-liver axis
    Gyongyi Szabo
    Shashi Bala
    World Journal of Gastroenterology, 2010, 16 (11) : 1321 - 1329